Allianz Asset Management Gmb H Sage Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

$62.9 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$16.75 - $48.98 $969,021 - $2.83 Million	-57,852 Reduced 53.56%	50,158 $1.03 Million
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $331,825 - $486,025	-8,163 Reduced 7.03%	108,010 $5.08 Million
Q1 2023 May 11, 2023	BUY	$37.27 - $46.57 $947,142 - $1.18 Million	25,413 Added 28.0%	116,173 $4.87 Million
Q4 2022 Feb 13, 2023	BUY	$32.2 - $43.61 $1.12 Million - $1.52 Million	34,812 Added 62.22%	90,760 $3.46 Million
Q3 2022 Nov 08, 2022	BUY	$32.28 - $43.27 $1.81 Million - $2.42 Million	55,948 New	55,948 $2.19 Million

Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $2.81 Million - $3.57 Million	-75,768 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$40.26 - $57.37 $1.51 Million - $2.16 Million	37,590 Added 98.46%	75,768 $3.36 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $698,622 - $1.01 Million	-12,730 Reduced 25.01%	38,178 $2.17 Million
Q1 2021 May 13, 2021	BUY	$70.65 - $96.76 $2.7 Million - $3.69 Million	38,168 Added 299.59%	50,908 $3.81 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $744,143 - $1.13 Million	12,740 New	12,740 $1.1 Million
Q1 2020 May 14, 2020	SELL	$26.15 - $77.24 $732,069 - $2.16 Million	-27,995 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$60.18 - $154.77 $5.84 Million - $15 Million	-97,024 Reduced 77.61%	27,995 $2.02 Million
Q3 2019 Nov 13, 2019	SELL	$140.29 - $189.96 $1,402 - $1,899	-10 Reduced 0.01%	125,019 $17.6 Million
Q2 2019 Aug 08, 2019	BUY	$157.85 - $183.09 $1.97 Million - $2.28 Million	12,460 Added 11.07%	125,029 $22.9 Million
Q1 2019 May 13, 2019	BUY	$89.33 - $163.65 $7.83 Million - $14.3 Million	87,665 Added 352.01%	112,569 $17.9 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $1.07 Million - $1.83 Million	-13,082 Reduced 34.44%	24,904 $2.34 Million
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $910,655 - $1.14 Million	-6,488 Reduced 14.59%	37,986 $5.95 Million
Q1 2018 May 14, 2018	BUY	$152.15 - $192.33 $6.13 Million - $7.75 Million	40,288 Added 962.45%	44,474 $7.16 Million
Q4 2017 Feb 13, 2018	SELL	$60.72 - $167.34 $210,576 - $580,335	-3,468 Reduced 45.31%	4,186 $689,000
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $188,866 - $272,287	3,076 Added 67.19%	7,654 $477,000
Q2 2017 Aug 14, 2017	SELL	N/A	-3,088 Reduced 40.28%	4,578 $365,000
Q1 2017 Apr 17, 2019	BUY	N/A	7,666	7,666 $545,000

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account